Request Deal Involvement

RA Capital Management led a $90m Series C round in SpyGlass Pharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

SPYGLASS PHARMA

target

SPYGLASS PHARMA

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

VENSANA CAPITAL

bidder

VENSANA CAPITAL

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

VERTEX VENTURES

bidder

VERTEX VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - RA Capital Management led a $90m Series C round in SpyGlass Pharma.